The FDA publishes less than a third of research for drug safety updates, and Yale researchers said the “spontaneous reporting” highlights the need for greater transparency.
Read the full post on Becker's Hospital Review - Healthcare News
Yale researchers urge transparency from FDA’s drug safety signals
